The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Level | Code | Title | |
---|---|---|---|
1 | J | Antiinfectives for systemic use | |
2 | J05 | Antivirals for systemic use | |
3 | J05A | Direct acting antivirals | |
4 | J05AH | Neuraminidase inhibitors |
Code | Title | |
---|---|---|
J05AH01 | Zanamivir | |
J05AH02 | Oseltamivir | |
J05AH03 | ||
J05AH04 |
Active Ingredient | Description | |
---|---|---|
Laninamivir |
|
|
Oseltamivir |
Oseltamivir (oseltamivir carboxylate) is a selective inhibitor of influenza virus neuraminidase enzymes, which are glycoproteins found on the virion surface. Viral neuraminidase enzyme activity is important both for viral entry into uninfected cells and for the release of recently formed virus particles from infected cells, and for the further spread of infectious virus in the body. |
|
Peramivir |
Peramivir is an inhibitor of influenza virus neuraminidase, an enzyme that releases viral particles from the plasma membrane of infected cells and is also important for viral entry into uninfected cells, which causes further spread of infectious virus in the body. |
|
Zanamivir |
Zanamivir is a selective inhibitor of neuraminidase, the influenza virus surface enzyme. Neuraminidase inhibition occurred in vitro at very low zanamivir concentrations (50% inhibition at 0.64nM–7.9nM against influenza A and B strains). |
Title | Information Source | Document Type | |
---|---|---|---|
DECTOVA Solution for infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
EBILFUMIN Hard capsule | European Medicines Agency (EU) | MPI, EU: SmPC | |
NATFLU Hard capsule | Health Sciences Authority (SG) | MPI, Generic | |
OSELFLU Gelatin capsule | Health Products Regulatory Authority (ZA) | MPI, Generic | |
RELENZA Inhalation powder, pre-dispensed | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
TAMIFLU Hard capsule | European Medicines Agency (EU) | MPI, EU: SmPC | |
TAMIFLU Powder for oral suspension | European Medicines Agency (EU) | MPI, EU: SmPC |